Category: Insulet Corp.Syndicate content

2014 in review: Changes at the top for medical device companies

December 22, 2014 by MassDevice staff

There was a significant amount of turnover this year in the corner offices of medical device companies, including exits by some of medtech's biggest names.

2014 in review: Changes at the top for medical device companies

There was a revolving door on medtech's corner office this year, with more than 35 CEOs leaving their positions through planned transitions, retirement or termination, according to a MassDevice.com analysis.

Insulet gains on Q3 numbers, names new CFO

November 6, 2014 by Brad Perriello

Insulet shares gain after the insulin management company turns in solid 3rd-quarter numbers and names a company insider to be its new CFO.

Insulet gains on Q3 numbers, names new CFO

Insulet (NSDQ:PODD) shares are up today after the insulin management company said its 3rd-quarter earnings topped expectations and named a new finance chief.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Insulet CEO DeSisto steps down

September 16, 2014 by Brad Perriello

Longtime Insulet CEO Duane DeSisto is leaving the corner office, to be replaced by former Cytyc chief Patrick Sullivan.

Insulet CEO DeSisto steps down

Insulet (NSDQ:PODD) said today that longtime CEO Duane DeSisto is stepping down after a 13-year run at the insulin management company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic CEO Ishrak seeks to reassure employees on MDT-COV deal | The week in medtech M&A

August 20, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Amid political noise, Ishrak seeks to reassure employees on Medtronic-Covidien deal; Will Medtronic follow Walgreen and abandon inversion in Covidien deal?; Medtronic founder Bakken backs Covidien buy; Allergan-Valeant update: SEC launches Ackman probe, Allergan pays up to $588M for Liris bladder drug, Ackman dangles IPO; Allergan CFO Edwards steps down amid hostile Valeant takeover bid

Amid political noise, Ishrak seeks to reassure employees on Medtronic-Covidien deal

August 15, 2014 by Brad Perriello

Allergan CFO Edwards steps down amid hostile Valeant takeover bid | Personnel Moves

August 18, 2014 by Brad Perriello

Allergan CFO Jeff Edwards is stepping down amid a $44 billion hostile takeover bid from Valeant Pharmaceuticals and Pershing Square Capital Management.

Allergan CFO Edwards steps down amid hostile Valeant takeover bid | Personnel Moves

Allergan (NYSE:AGN) said today that longtime CFO Jeff Edwards is stepping down to honor a commitment he made to his family earlier this year, replaced by treasurer Jim Hindman effective immediately.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes and data: DexCom, Insulet share data in pursuit of app-based diabetes manager

August 8, 2014 by Arezu Sarvestani

DexCom agrees to share more of its continuous glucose monitoring data with Insulet's wireless smartphone-based "Personal Diabetes Manager."

Diabetes: DexCom and Insulet share data for a 'personal diabetes manager'

Medtech leaders talk mistakes, challenges and opportunities at DeviceTalks

July 16, 2014 by Arezu Sarvestani

Top execs from Haemonetics, Kips Bay and others open up about their biggest regrets, debate market pressures facing the medtech industry and offer advice for young entrepreneurs.

Medtech CEOs talk mistakes, challenges and opportunities at DeviceTalks

A group of medtech insiders gathered in Boston last night to talk shop, share stories and glean insight from some of the industry's brightest minds at MassDevice's DeviceTalks East conference.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp